These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1078621)

  • 1. Theoretical approach to molecular biology of factor VIII: heterogeneity of the molecule.
    Gralnick HR; Marchesi SL; Coller BS
    Ann N Y Acad Sci; 1975 Jan; 240():378-88. PubMed ID: 1078621
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunologic evidence that the antihemophilic factor (factor VIII)-like material in hemophilic plasma possesses a nonfunctional low molecular weight subcomponent.
    Poon MC; Ratnoff OD
    Blood; 1977 Sep; 50(3):367-76. PubMed ID: 301759
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunological studies of factor VIII in haemophilia and von Willebrand's disease.
    Gralnick HR; Coller BS; Marchesi SL
    Nat New Biol; 1973 Aug; 244(139):281-2. PubMed ID: 4199570
    [No Abstract]   [Full Text] [Related]  

  • 4. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of clotting on structure and function of human factor VIII.
    Gordon NR; Shulman NR
    Ann N Y Acad Sci; 1975 Jan; 240():79-83. PubMed ID: 1078623
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelet-bound ristocetin aggregation factor in normal subjects and patients with von Willebrand's disease.
    Green D; Potter EV
    J Lab Clin Med; 1976 Jun; 87(6):976-86. PubMed ID: 778313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Von Willebrand factor: dissociation from antihemophilic factor procoagulant activity.
    Weiss HJ; Hoyer IW
    Science; 1973 Dec; 182(4117):1149-51. PubMed ID: 4127287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemophilia and von Willebrand's disease. Some biological determinants. H. P. Smith memorial lecture.
    Brinkhous KM
    Am J Clin Pathol; 1975 May; 63(5):609-17. PubMed ID: 1093384
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunological characterization of purified anti-haemophilic factor A (factor VIII) which corrects abnormal platelet retention in Von Willebrand's disease.
    Bouma BN; Wiegerinck Y; Sixma JJ; Van Mourik JA; Mochtar IA
    Nat New Biol; 1972 Mar; 236(65):104-6. PubMed ID: 4112547
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the Factor VIII/von Willebrand factor antigen on human platelets.
    Coller BS; Hirschman RJ; Gralnick HR
    Thromb Res; 1975 Jun; 6(6):469-80. PubMed ID: 1098217
    [No Abstract]   [Full Text] [Related]  

  • 11. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcellular platelet factor VIII antigen and von Willebrand factor.
    Nachman RL; Jaffe EA
    J Exp Med; 1975 May; 141(5):1101-13. PubMed ID: 1168691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-haemophilic factor, normal and abnormal.
    Bennett B
    Br J Haematol; 1974 Jan; 26(1):1-7. PubMed ID: 4604099
    [No Abstract]   [Full Text] [Related]  

  • 14. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.
    Weiss HJ; Meyer D; Rabinowitz R; Pietu G; Girma JP; Vicic WJ; Rogers J
    N Engl J Med; 1982 Feb; 306(6):326-33. PubMed ID: 6798442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the human factor VIII/von Willebrand's factor protein. II. Identification and characterization of the von Willebrand protein.
    Gralnick HR; Coller BS
    Blood; 1975 Sep; 46(3):417-30. PubMed ID: 1080062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Participation of von Willebrand factor in blood platelet functions].
    Mikami S; Takahashi Y; Nishino M; Fukui H
    Nihon Rinsho; 1978 Dec; 36(12):3824-9. PubMed ID: 372620
    [No Abstract]   [Full Text] [Related]  

  • 17. [Structure and function of clotting factor VIII: the results of fundamental research].
    Beck EA; Furlan M
    Ther Umsch; 1979 Apr; 36(4):294-300. PubMed ID: 377554
    [No Abstract]   [Full Text] [Related]  

  • 18. A 1973 look at hemophilia and von Willebrand's disease.
    Ratnoff OD
    Proc Inst Med Chic; 1973; 29(9):296-304. PubMed ID: 4581203
    [No Abstract]   [Full Text] [Related]  

  • 19. The cold-insoluble globulin of plasma and its relationship to factor VIII.
    Cooper HA; Wagner RH; Mosesson MW
    J Lab Clin Med; 1974 Aug; 84(2):258-63. PubMed ID: 4135593
    [No Abstract]   [Full Text] [Related]  

  • 20. Nature of von Willebrand factor: a new assay and a specific inhibitor.
    Sarji KE; Stratton RD; Wagner RH; Brinkhous KM
    Proc Natl Acad Sci U S A; 1974 Aug; 71(8):2937-41. PubMed ID: 4547258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.